top of page

Key Considerations for Selecting the Right CRO for Your Clinical Trial

  • Sep 30, 2025
  • 1 min read
The cost of delay can be more than 800K.

80% of clinical trials miss enrollment targets, and each day of delay costs $800K in lost sales.

 

Choosing a CRO isn’t just procurement. It’s a strategic decision.

 

Rubix LS builds partnerships based on transparency and trust, giving sponsors real-time insights, aligned incentives, and faster, more reliable trial outcomes.

 

Turn your CRO from a cost center into a strategic advantage. Make it the right CRO.

 

Read the full white paper here:



image.png
  • LinkedIn
  • Facebook
  • Twitter
  • Instagram
  • Whatsapp

Rubix LS: We’re the Health Outcomes Architect Company, designing a healthier future for every community.

image.png

Join our mailing list

image.png
image.png

Let’s Talk About Your Program

Whether you’re planning a proof-of-concept study, need a CRO to run a Phase I/II trial, or are building a federal health research initiative, we can support you.

Copyright © 2026 Rubix Life Sciences | Privacy Policy

bottom of page